How to Find Undervalued Pokemon Cards in 2026
Finding undervalued Pokemon cards requires looking beyond surface-level prices. The most profitable opportunities exist where the market hasn't caught up to the data.
The Three Signals That Matter
1. Grading Multiple The ratio between a card's raw (ungraded) price and its PSA 10 price is the single most important metric. A card selling raw for $5 with PSA 10s at $200 has a 40x multiple — massive upside if you can get the grade. Cards with multiples above 10x deserve serious attention.
2. Supply Cycle Position Sets go out of print (OOP) on a predictable schedule. Once a set stops being printed, the supply of raw cards freezes. If demand stays constant or grows, prices rise. The best time to buy is 6-12 months before a set goes OOP — smart money enters early.
3. Probability of Profit Not every high-multiple card is worth grading. You need to factor in the gem rate (percentage that grade PSA 10), grading costs, and selling fees. A card with a 5% gem rate and 50x multiple might still be unprofitable. SlabQuant runs 10,000 Monte Carlo simulations per card to calculate your actual probability of making money.
Where to Look
Focus on Illustration Rares and Special Illustration Rares from recent sets that are approaching or past their print runs. These have the highest collector demand and typically the best grading multiples. Japanese cards often offer better value than English equivalents due to lower collector competition in Western markets.
Common Mistakes
- Chasing hype: If everyone on social media is talking about a card, you're probably too late
- Ignoring liquidity: A PSA 10 worth $500 means nothing if only 2 sell per month
- Forgetting fees: PSA grading ($25), eBay fees (13%), shipping — these eat into margins fast
The best approach is systematic: let the data tell you where the opportunities are, then verify with your own research.
Try SlabQuant Free
Analyze any Pokemon card in seconds. BUY/HOLD/SELL signals powered by quantitative analysis.
Analyze a CardSlabQuant analysis is for informational purposes only and does not constitute financial advice.